Patent · US Expired

Vaccines containing ribavirin and methods of use thereof

US7241440B2 · kind B2 · utility

4Cited by

75References

34Claims

0Family size

Assignee

TRIPEP AB · SE

Inventors

Matti Sallberg · Stockholm, SE
Catharina Hultgren · Stockholm, SE

Key dates

Filing date	Apr 2, 2004
Grant date	Jul 10, 2007
Priority date	—
Expiry date	Jul 6, 2024

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for enhancing the effect of vaccines in animals, such as domestic, sport, or pet species, and humans are disclosed. More particularly, vaccine compositions comprising ribavirin and an antigen, preferably an antigen that has an epitope present in Hepatitis C virus (HCV), are disclosed for use in treating and preventing disease, preferably HCV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.